AstraZeneca Pharma India has informed that it enclosed Certificate dated May 2, 2024 issued by Integrated Registry Management Services, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
The above information is a part of company’s filings submitted to BSE.